Status:
UNKNOWN
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
Lead Sponsor:
Peking University
Collaborating Sponsors:
Beijing Municipal Science & Technology Commission
Peking Union Medical College Hospital
Conditions:
Gastric Cancer
Gastrostomy
Eligibility:
All Genders
18+ years
Brief Summary
The real world based multi-cohorts study aims to evaluate the safety and effectiveness of function preserving gastrectomy including pylorus-preserving distal gastrectomy, proximal gastrectomy and wedg...
Detailed Description
Gastric cancer patients with clinical stage T1/2 will be screened for the study. For the patients enrolled, a multidisciplinary discussion will be performed to evaluate the proper gastrectomy for the ...
Eligibility Criteria
Inclusion
- Karnofsky performance over 70%
- Histologically proven gastric or gastroesophageal joint adenocarcinoma with clinical stage T1-2N0-3M0
- No severe comorbidity with estimated survival less than 5 years
Exclusion
- pregnancy
- Signs of distant metastases
- received chemotherapy, radiotherapy, immune therapy
- received gastrectomy
- other malignant tumors within 5 years except for cured skin cancer and cervical caner in situ.
- uncontrolled epilepsy, central nervus system disease or mental disease that affect the compliance of treatment and follow-up
- severe heart disease
- organ transplantation that needs immunosuppressor
- emergency surgery due to hemorrhage, perforation and ileus of gastric cancer
Key Trial Info
Start Date :
March 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03874871
Start Date
March 20 2019
End Date
March 1 2025
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142